top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
3D Printing of Pharmaceuticals and Drug Delivery Devices
3D Printing of Pharmaceuticals and Drug Delivery Devices
Autore Lamprou Dimitrios A
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (436 p.)
Soggetto topico Medicine
Soggetto non controllato 3D bio-inks
3D bio-printing
3D bioprinting
3D printed drug products
3D printed oral dosage forms
3D printing
acetaminophen
additive manufacturing
amorphous solid dispersion
anti-infective devices
antioxidant materials
aspirin (acetylsalicylic acid)
beads
biodegradable
biofilm formation
bioprinting
chemical modification
chronotherapeutic delivery
complex structures
computer-aided design (CAD)
computer-aided design (CAD) design
controlled release
cyclodextrin
digital light processing technology
digital pharmacy
dissolution kinetics
drug delivery
drug development
drug release
extrusion
extrusion-based 3D printing
feature size
filament extrusion
fixed dose combination
fixed-dose combinations
floating systems
FMD
fused deposition modeling
fused deposition modeling (FDM)
fused deposition modeling 3D printing
Fused Deposition Modeling 3D Printing
fused deposition modelling
fused filament fabrication
fused layer modeling
gastric floating
gastro-retentive floating system
geometry
gums
high API load
high-precision targeting
hospital pharmacy
hot-melt extrusion
implantable devices
implantable scaffold
inkjet printing
lignin
materials
mechanical properties
micro-implant
micro-swimmer
micromedicine
microneedle
modified drug release
modified release
MTT assay
multiple units
multiple-layer dosage forms
neural networks
on-demand manufacturing
optimization
oral dosages
oral powder
orodisperible films
orodispersible discs
orodispersible film
paracetamol (acetaminophen)
patient-specific
pectin
pediatric
pelvic organ prolapse
personalised medicines
personalized medicine
personalized medicines
personalized pharmaceuticals
pharmaceutical quality control
pharmaceuticals
pharmaceutics
pharmacoprinting
photopolymerization
polylactic acid
polymeric ink
polymers
poor solubility
prediction
pregabalin
pressure-assisted microsyringe (PAM)
printlets
process
processing parameters
prolonged drug delivery
propolis
pseudo-bone
pulsatile release
release profile
resolution
semisolid extrusion 3D printing
solid dosage forms
spheroids
stencil printing
stereolithography
stress urinary incontinence
structural design
subcutaneous
sustained drug release tablets
tablets
telemedicine
theophylline
three dimensional printing
three-dimensional printing
vaginal meshes
vascularization
vat polymerisation
warfarin
wound dressing
wound-healing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557780703321
Lamprou Dimitrios A  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumor and Anti-HIV Agents from Natural Products
Antitumor and Anti-HIV Agents from Natural Products
Autore Nakagawa-Goto Kyoko
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (338 p.)
Soggetto topico Research & information: general
Soggetto non controllato acute toxicity
allyl isothiocyanate
Angelica dahurica
anti-HIV
antiangiogenic
antioxidants
antiproliferation
antiproliferative activity
antiretroviral agents
antitumor activity
apoptosis
Artemisia absinthium L.
aspidosperma-type
benzyl isothiocyanate
bladder cancer
Bousigonia mekongensis
BRAF inhibitor
breast cancer
butanolides
caffeic acid
cancer
cancer multidrug resistance
cancer stem cell
Carpesium divaricatum
cell cycle
cell cycle arrest
cervical cancer
chemistry
chemoprevention
cisplatin
coumarins
curcumin analog
cytotoxicity
delcosine
delpheline
diterpenoid alkaloids
DOTA
drug development
drug-drug interaction
epithelial-to-mesenchymal transition
essential oil
flavonoids
G2/M phase cell cycle arrest
HaCaT cells
HEF cell line
hepatocellular carcinoma
hepatoma cells
Hernandia nymphaeifolia
human tumor cell lines
human tumor cells
inflammation
Ivalin
kobusine
lignan glycosides
lipojesaconitine
marine metabolites
matrix metalloproteinase
medicine
melanoma
melanoma and breast cancer cell line
Mentha aquatica var. Kenting Water Mint
metastasis
mitochondria-mediated apoptosis
monoterpenoid indole alkaloids
natural agents
natural phaeosphaeride A
natural products
NF-κB
oral squamous cell carcinoma cells
oxidative stress
oxypeucedanin
P-glycoprotein
p53
phenethyl isothiocyanate
phenolic acid
pseudokobusine
pterostilbene
quercetin
reactive oxygen species
resveratrol
SK-Hep-1
sulforaphane
tamoxifen
taxol
total phenolic content
transforming growth factor-β1
triterpenoids
tubulin inhibitor
tumor suppression
two-stage skin carcinogenesis
ursolic acid
β-lapachone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557504803321
Nakagawa-Goto Kyoko  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cell-Free Synthetic Biology
Cell-Free Synthetic Biology
Autore Hong Seok Hoon
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (152 p.)
Soggetto topico History of engineering and technology
Soggetto non controllato antimicrobials
artificial cell
bioconversion platform
cell-free metabolic engineering
cell-free metabolic engineering (CFME)
cell-free protein expression (CFPE)
cell-free protein synthesis
cell-free protein synthesis (CFPS)
cell-free synthetic biology
cell-free transcription-translation
CFPS
chaperones
colicins
DNA origami
drug development
E. coli crude extract preparation
enzymes
eukaryotic lysates
genomically engineered E. coli
growth factors
in vitro protein synthesis
in vitro transcription-translation (TX-TL)
in vitro translation
ischemic stroke
mathematical model
microsomes
n/a
protein production
rapid prototyping
riboregulator
sonication
synthetic biology
tissue plasminogen activator
tPa
unnatural amino acid
unnatural protein
ISBN 3-03928-023-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910372785403321
Hong Seok Hoon  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Converging Nanochemistry: From Disease Prevention to Diagnosis and Treatment
Converging Nanochemistry: From Disease Prevention to Diagnosis and Treatment
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2023
Descrizione fisica 1 online resource (210 p.)
Soggetto topico Technology: general issues
Soggetto non controllato Andes virus
antibody
anticancer
antiproliferation
APN receptor
apoptosis
artificial intelligence
bacterial nanocellulose
biomarker particles
biopanning
cancer biomarker
CDR randomization
cell death
chemoprevention
colon cancer
colorectal cancer
conjugation strategy
controlled drug delivery system
covalent bonding
drug development
drug repurposing
early detection
electrochemical glycobiosensor
encapsulation
epidermal growth factor
fungal pathogens
genistein
glycan
in situ
infectious disease
inflammation
MEK inhibitors
miRNA
molecular docking
nanobody
nanomaterial
new therapeutic targets
non-covalent bonding
parasporin
phage display
protein modeling
protein structure
reactive oxygen species
site-directed mutagenesis
structural bioinformatics
styrylquinolines
surface modification
synthetic library
tumor necrosis factor
vascular endothelial growth factor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Converging Nanochemistry
Record Nr. UNINA-9910743276003321
MDPI - Multidisciplinary Digital Publishing Institute, 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug Delivery Technology Development in Canada
Drug Delivery Technology Development in Canada
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 online resource (352 p.)
Disciplina 615.1/900971
Soggetto topico Medicine and Nursing
Soggetto non controllato 3D spheroid
adenanthin
amphotericin B
antibodies
bacteriophage
bioaccessibility
biodistribution
biological barriers
biologicals
blood-brain barrier
blood-brain barrier (BBB)
Canada
cancer
canola oil deodorizer distillate
cationic gemini surfactant
child friendly formulation
chronotherapy
circadian clock
cisplatin
clinical trials
co-delivery
combination therapy
controlled drug delivery
developing world
dissolution
DOX-Vit D
doxorubicin
drug delivery
drug delivery systems
drug development
drug discovery
drug-resistant melanoma
EGFR-targeted therapy
emulsion
encapsulation
flavonoids
formulation and dosage form development
fungal infections
gambogic acid
gastrointestinal simulator
GE11 peptide
HAV6 cadherin peptide
head and neck squamous cell carcinoma
HIF-1
hypoxia-induced chemoresistance
inclusion complex
innovation
intra-arterial chemotherapy
lipid nanoparticles
liposome
liposomes
loading gradients
magnetic fields
magnetic resonance imaging (MRI)
malignant gliomas
medical devices
medulloblastoma
mefloquine
melphalan
Metaplex
MG63
model orange juice
mouse models
nanoparticles
nifedipine
oral
oral delivery
oral formulation
parasitic infections
permeation enhancers
phage display
pharmaceutics
pharmacokinetics
pharmacological Inhibitors of HIF-1 and STAT3
phospholipid complex
photostabilizers
phytosterols
plant
polymeric micelle
precision medicine
primary central nervous system lymphomas
quercetin
radiation
radiolabeling
remote loading
ROESY NMR spectroscopy
rosmarinic acid
route of administration
skin
small molecules
STAT3
staurosporine
sustained delivery
targeted therapies
throughput
TNO gastrointestinal model
tocopherols
topical formulation
transdermal drug delivery
transient modulation
translational research
triggered drug release
ultrasound
virus
Vitamin D
water miscible solvents
ISBN 3-03928-005-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367736503321
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging Therapeutic Approaches for Cystic Fibrosis
Emerging Therapeutic Approaches for Cystic Fibrosis
Autore Lopes-Pacheco Miquéias
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 online resource (281 p.)
Soggetto topico Pharmacology
Science: general issues
Soggetto non controllato cystic fibrosis transmembrane conductance regulator
drug development
infection
inflammation
lung
modulators
mutations
therapeutic approach
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557791403321
Lopes-Pacheco Miquéias  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Enzyme Inhibitor from Marine Organisms
Enzyme Inhibitor from Marine Organisms
Autore Tischler Dirk
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (130 p.)
Soggetto topico Research & information: general
Soggetto non controllato ACE inhibitory peptide
acetylcholinesterase
Alzheimer's disease
asperchalasine
BACE1
bioactives
drug development
enzyme inhibition
functional annotation
GH109 α-N-acetylgalactosaminidase
GH36 α-galactosidase
in silico docking
inactivation
inhibitor
kinase inhibitors
macroalgae
marine bacteria
marine fish
marine fungi
marine natural products
marine sponges
molecular docking
monanchomycalin B
monanhocidin A
Mycosphaerella sp
natural products
normonanhocidin A
optimization
pentacyclic guanidine alkaloids
phlorotannins
protease
purification
secondary metabolites
slow-binding irreversible inhibitor
sponge Monanchora pulchra
structural identification
structure-function relation
Ulva intestinalis
Ulva ohnoi
α-glucosidase
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557107603321
Tischler Dirk  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Basis and Gene Therapies of Cystic Fibrosis
Molecular Basis and Gene Therapies of Cystic Fibrosis
Autore Engelhardt John
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (210 p.)
Soggetto topico Medicine
Soggetto non controllato airway basal cell
baculovirus
biomarker
CFTR
CFTR gene
CFTR modulators
CFTR variants
CFTR-related disorders
common and new pathogenic variants
cyclophosphamide
cystic fibrosis
Cystic fibrosis
disease liability
drug development
enterotoxin gene cluster
ethnic Russian population
exosomes
functional assay
gene therapy
genotype-guided therapy
genotype-phenotype correlations
gut-lung axis
health policies
health policy
human nasal epithelial cells
incidence
insect cells
interpretation
lentivirus
lung
lung microbiome
metagenomics
microvesicles
miRNA
molecular diagnosis
MRSA
newborn screening
next generation sequencing
Next Generation Sequencing (NGS)
organoids
penetrance
pre-clinical in vitro models
primary cells
proteostasis
rAAV2/HBoV1
small molecules
Staphylococcus aureus
superantigen
survival
transcriptomics
transient immunosuppression
trypsinogen
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557392203321
Engelhardt John  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Biomarkers in Alzheimer's Disease
Novel Biomarkers in Alzheimer's Disease
Autore Villa Chiara
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (442 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato (18F)FDG
adipose tissue dysfunction
ageing
aging
Alzheimer disease
Alzheimer's disease
Alzheimer's disease (AD)
amyloid
amyloid beta
Amyloid Beta
amyloid beta peptide
amyloid cascade hypothesis
antioxidant
ApoE
APOE
APOE alleles
APP mutations
bacteria
behavioral and psychological symptoms of dementia (BPSD)
beta-amyloid
biofluids
biomarker
biomarkers
blood
cardiovascular risk factors
carotenoids
CART analysis
cerebrospinal fluid
clinical trials
Clock
clock genes
cognition
cognitive decline
COMT
cytokines
dementia
diabetes
diagnosis
diagnostic research
diagnostics
drug development
early diagnosis
early onset AD
EEG
endophenotypes
energetic metabolism
episodic memory
exosomes
familial AD
flotillin
genetic variants
genetics of AD
germline mutations
glucose metabolism
glycolytic reserve
inflammation
late onset AD
lysosomes dysfunction
membrane potential
messenger RNA
metabolomics
microRNA
mild cognitive impairment
mitochondrial
mitochondrial dysfunction
mitochondrial spare respiratory capacity
MTHFR
Multiplex
multivariate analysis
n/a
neurodegeneration
neurofilament light chain
neuroimaging
neuroinflammation
neuropsychiatry inventory scale (NPI)
neuropsychological assessment
neuropsychology
neurotropic microbes
NfL
nutrition
obesity
older adults
omega-3 fatty acids
person-tailored
PET/CT
phonemic fluency
phosphorylated tau
physical performance
precision medicine
prognostics
PSEN1
PSEN2
semantic memory
semantic priming
SiMoA
soluble TREM2
subjective cognitive decline
synaptic biomarkers
tau
Tau
TMS
total tau
Type-3-Diabetes
virus
vitamin E
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557129403321
Villa Chiara  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Targets and Biomarkers in Solid Tumors
Novel Targets and Biomarkers in Solid Tumors
Autore Yang Dong-Hua
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 online resource (285 p.)
Soggetto topico Pharmacology
Science: general issues
Soggetto non controllato biomarker
drug development
solid tumor
target
therapeutics
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557743003321
Yang Dong-Hua  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui

Opere

Altro...

Lingua di pubblicazione

Altro...

Data

Data di pubblicazione

Altro...